Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Clinical Interventions in Aging|March 14, 2009
Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancerStefano Gonnelli, Roberto PetrioliWorld Journal of Clinical Oncology|October 16, 2015
Is there still a place for docetaxel rechallenge in prostate cancer?Roberto Petrioli, Edoardo Francini, Giandomenico RovielloExpert Review of Anticancer Therapy|August 20, 2014
No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamideEdoardo Francini, Roberto Petrioli, Giandomenico RovielloCritical Reviews in Oncology/Hematology|April 23, 2015
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent resultsFranco Roviello, Giandomenico Roviello, Roberto Petrioli, et al.Critical Reviews in Oncology/Hematology|June 9, 2015
The third line of treatment for metastatic prostate cancer patients: Option or strategy?Giandomenico Roviello, Roberto Petrioli, Letizia Laera, et al.Clinical Genitourinary Cancer|July 16, 2020
Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving IssueGiandomenico Roviello, Roberto Petrioli, Donata Villari, et al.Future Oncology (London, England)|January 25, 2020
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patientSalvatora Tindara Miano, Edoardo Francini, Roberto Petrioli, et al.Investigational New Drugs|March 18, 2019
Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?Giandomenico Roviello, Navid Sohbani, Roberto Petrioli, et al.Cancer Management and Research|October 29, 2020
FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic CancerMartina Catalano, Raffaele Conca, Roberto Petrioli, et al.Journal of Oncology|July 30, 2019
Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than LightsGiandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, et al.Pageof 11